TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment

This study has been completed.
Sponsor:
Collaborators:
Global Alliance for TB Drug Development
Bayer
Information provided by:
Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier:
NCT00144417
First received: September 1, 2005
Last updated: August 2, 2011
Last verified: June 2011